t-guard
Showing 1 - 2 of 2
Steroid-Refractory Acute GVHD Trial in Worldwide (T-Guard, Ruxolitinib)
Terminated
- Steroid-Refractory Acute Graft Versus Host Disease
- T-Guard
- Ruxolitinib
-
Birmingham, Alabama
- +47 more
Jan 22, 2023
Steroid-Refractory Acute GVHD Trial in United States (T-Guard)
Terminated
- Steroid-Refractory Acute Graft Versus Host Disease
- T-Guard
-
Duarte, California
- +23 more
Dec 7, 2021